Talha Badar
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Talha Badar
Jul 26, 2024, 00:17 |
Insight
Anand Patel: Analysis of intensive chemotherapy in CBF-AML
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of…
Jul 23, 2024, 06:05 |
Blog
Talha Badar: The role of allogeneic stem cell transplantation in Ph+ve ALL
Talha Badar shared on X: "The role of allogeneic stem cell transplantation in Ph+ve ALL? Outcome…
Jul 15, 2024, 21:23 |
Insight
Zhuoer Xie: Risk Prediction for Clonal Cytopenia
Zhuoer (Zoey) Xie, Hematologist at Moffitt Cancer Center, shared on X about a recent paper…
Jul 15, 2024, 21:23 |
Insight
Herculean effort on risk prediction model for clonal cytopenias
UChicago Leukemia Program shared a post on X about a recent paper by Zhuoer Xie et…
Jul 15, 2024, 13:21 |
Blog
Talha Badar: CRh as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia
Talha Badar shared on X: "Complete remission with partial hematological recovery as a palliative endpoint for…
Jul 9, 2024, 13:43 |
Blog
Oncoinfluencers to Follow on Social Media: Dr. Talha Badar
At OncoDaily, we are excited to feature Dr. Talha Badar, a leading hematologist/oncologist, as our…
Jul 9, 2024, 00:57 |
Insight
Talha Badar: Outcome after stopping venetoclax and azacitidine
Talha Badar shared on X: “American Journal of Hematology, Blood Research Journal, Wiley Online Library.…
Jun 18, 2024, 23:17 |
Insight
Talha Badar: TP53 mutation in Myeloproliferative neoplasms
Talha Badar shared on X: , "Genomic landscape, impact allelic burden, time to…
Jun 18, 2024, 23:12 |
Insight
Koschmieder: Current standard and novel targets for myelofibrosis
Talha Badar shared on X: . "Koschmieder: current standard and novel targets…
Jun 18, 2024, 23:07 |
Insight
Palandri: State of the art talk on PV at EHA2024
Talha Badar shared on X: . "Palandri: state…
Jun 18, 2024, 23:01 |
Insight
Dr. Naval Daver presented results of ENHANCE-3 study at EHA2024
Talha Badar shared on X: . "Dr. Naval Daver: Presented results of…
Jun 18, 2024, 02:57 |
Blog
Skoda: clonal evolution of Myeloproliferative Neoplasms
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared on X: “Skoda: clonal…
Jun 17, 2024, 07:05 |
Societies
15 Posts You Should Not Miss From EHA 2024!
The European Hematology Association (EHA) Hybrid Congress or EHA2024 will took place in Madrid, Spain…
Jun 16, 2024, 19:23 |
Blog
Talha Badar on Copland
Talha Badar shared a post on X: "Copland: Targeting alternating pathway in CML/CML-AP/CML-BP. 1) MDM2i…
Jun 15, 2024, 07:20 |
Drugs
Talha Badar: Optimization of venetoclax based therapy
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared on X: “Wei: Optimization…
May 20, 2024, 14:02 |
Blog
Talha Badar: Rx of Lower risk MDS, non del 5q, failing ESA/luspatercept
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on X:…
May 14, 2024, 10:05 |
Blog
Amalya Sargsyan: Novel weapons in LCSM to be presented at ASCO
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post on X:…
May 8, 2024, 01:20 |
Drugs
Talha Badar: Myelofibrosis after failure of Ruxolitinib
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on Twitter/X:…
Apr 28, 2024, 11:34 |
Insight
Talha Badar: Clinical significance of RAS mutation in AML
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center, shared a post on X:…
Apr 21, 2024, 18:36 |
Blog
Talha Badar: Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
Talha Badar, Assistant Professor of Oncology at Mayo Clinic, shared a post on X: “Real-World…
Apr 16, 2024, 01:37 |
Insight
Talha Badar: A brief overview on MLL gene re-arranged AL in this thread
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a thread on X/Twitter: "Weekend review: MLL- rearrange…
Apr 11, 2024, 15:15 |
Insight
Talha Badar: Efficacy of autologous and allogeneic hematopoietic cell transplantation in Acute Promyelocytic Leukemia
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: “Efficacy of autologous and…
Apr 11, 2024, 13:10 |
Insight
Talha Badar: Differentiation syndrome with targeted therapies for myeloid malignancies
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: "Weekend review 1/6 Differentiation syndrome…
Apr 1, 2024, 23:39 |
Insight
Talha Badar: A multicenter study of posttransplantation low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia
Talha Badar, Hematologist/Oncologist at Mayo Clinic, shared a post on X/Twitter: "A multicenter study of…
Mar 27, 2024, 13:57 |
Blog
Talha Badar: Transplant or not to transplant for TP53m AML
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X/Twitter: "Weekend review…
Mar 9, 2024, 13:00 |
Blog
Talha Badar: Brief thread on sequencing of Blina and InO
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X: “Weekend review:…
Mar 5, 2024, 01:11 |
Blog
Talha Badar: Outcome of MDS progressing on hypomethylating agent
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X: "Weekend review:…
Feb 18, 2024, 15:21 |
Blog
Talha Badar: Salvage therapy for relapse APL and outcome
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X: "Weekend…
Feb 13, 2024, 08:00 |
Blog
Talha Badar: Brief review focusing on VEN and HMA triplets in AML
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a thread on X/Twitter: "Weekend…
Feb 6, 2024, 04:40 |
Blog
Talha Badar: Weekend review. Venetoclax for NPM1m
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X/Twitter: "Weekend…
Feb 3, 2024, 13:53 |
Drugs
Talha Badar: Upfront immunotherapy with or without chemotherapy for precursor B-cell ALL
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Upfront immunotherapy +/-…
Jan 27, 2024, 08:05 |
Blog
Talha Badar: Outcome of patients progressing after venetoclax based therapies
Talha Badar, Hematologist/Oncologist at Mayo Clinic in Jacksonville, Florida, shared a post on X/Twitter: "…
Jan 14, 2024, 15:31 |
Insight
Talha Badar: Brief review of menin inhibitors in clinical trials.
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Jan 9, 2024, 19:11 |
Blog
Talha Badar: What is the right duration of VENETOCLAX with HMA for AML
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Jan 5, 2024, 17:36 |
Insight
Talha Badar: What is the right duration of Venetoclax with HMA for AML?
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, shared on X/Twitter:…
Jan 1, 2024, 04:39 |
Blog
Talha Badar: Long-Term Results of the Dasatinib-Blinatumomab Protocol for Adult Philadelphia-Positive ALL here
Talha Badar, Hematologist/Oncologist at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "Long-Term Results of the…
Dec 23, 2023, 03:22 |
Blog
Talha Badar: ASH23 Highlights for me
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 12, 2023, 20:51 |
Blog
Talha Badar: Dr. Gangat presenting Mayo Clinic Comprehensive Cancer Center data on AML pts Rx with VEN+HMA
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter: "ASH23…
Dec 12, 2023, 18:26 |
Blog
Talha Badar: Our abstract studying immune clustering via CyTOF in AML pts receiving VEN+HMA
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 11, 2023, 17:54 |
Insight
Talha Badar: ASH23, a few selected CML abstracts to watch out at this year ASH
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 9, 2023, 16:30 |
Insight
Talha Badar: ASH23, a few selected MDS abstracts to watch out at this year ASH meeting
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Dec 8, 2023, 12:47 |
Insight
Talha Badar: A few selected ALL abstracts to watch for at ASH23
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Nov 3, 2023, 12:29 |
Insight
Talha Badar: In view of recent approval of IDH1i in MDS brief tweetorial
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on X/Twitter:…
Oct 25, 2023, 18:04 |
Insight
Talha Badar: Moving immunotherapy upfront in B-cell ALL
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, posted on Twitter:…
Oct 3, 2023, 17:19 |
Drugs
Talha Badar: The story of Luspatercept!
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, recently tweeted: ''Weekend…
Aug 21, 2023, 17:03 |
Insight
Talha Badar: Prevalence and clinical expression of germ line predisposition to myeloid neoplasms in adults with marrow hypocellularity.
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, recently tweeted: "Prevalence…
Aug 21, 2023, 12:28 |
Blog
Talha Badar: I had a great time in presenting our real-world data on outcomes Ph+ ALL for Resonance Acute Leukemia Research and Care Network.
Quoting Talha Badar, an Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, stated…
Aug 14, 2023, 16:50 |
Insight
Talha Badar: Brief summary of 2 pivotal trials
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center, recently tweeted: "Brief summary of…
Jun 15, 2023, 16:18 |
Insight
Incorporation of arsenic significantly improve survival
In a post by Talha Badar on Twitter, it says,"Characteristics and outcomes of pts with…
All:
49
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube